Glenmede Trust’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,229
| Closed | -$17K | – | 1449 |
|
|
2020
Q3 | $17K | Buy |
2,229
+68
| +3% | +$519 | ﹤0.01% | 1670 |
|
|
2020
Q2 | $20K | Hold |
2,161
| – | – | ﹤0.01% | 1592 |
|
|
2020
Q1 | $8K | Hold |
2,161
| – | – | ﹤0.01% | 2509 |
|
|
2019
Q4 | $8K | Hold |
2,161
| – | – | ﹤0.01% | 2509 |
|
|
2019
Q3 | $10 | Hold |
2,161
| – | – | ﹤0.01% | 2340 |
|
|
2019
Q2 | $14 | Hold |
2,161
| – | – | ﹤0.01% | 2218 |
|
|
2019
Q1 | $16 | Hold |
2,161
| – | – | ﹤0.01% | 2171 |
|
|
2018
Q4 | $16 | Buy |
+2,161
| New | +$16 | ﹤0.01% | 2082 |
|
|
2018
Q3 | – | Sell |
-8,662
| Closed | -$98K | – | 1525 |
|
|
2018
Q2 | $98K | Buy |
+8,662
| New | +$98K | ﹤0.01% | 1264 |
|
|
2017
Q4 | – | Sell |
-19,008
| Closed | -$117K | – | 2692 |
|
|
2017
Q3 | $117K | Hold |
19,008
| – | – | ﹤0.01% | 1382 |
|
|
2017
Q2 | $84K | Hold |
19,008
| – | – | ﹤0.01% | 1431 |
|
|
2017
Q1 | $84K | Hold |
19,008
| – | – | ﹤0.01% | 1431 |
|
|
2016
Q4 | $102K | Hold |
19,008
| – | – | ﹤0.01% | 1397 |
|
|
2016
Q3 | $121K | Hold |
19,008
| – | – | ﹤0.01% | 1346 |
|
|
2016
Q2 | $85K | Hold |
19,008
| – | – | ﹤0.01% | 1395 |
|
|
2016
Q1 | $73K | Hold |
19,008
| – | – | ﹤0.01% | 1406 |
|
|
2015
Q4 | $105K | Sell |
19,008
-8,640
| -31% | -$47.7K | ﹤0.01% | 1345 |
|
|
2015
Q3 | $173K | Hold |
27,648
| – | – | ﹤0.01% | 1213 |
|
|
2015
Q2 | $169K | Hold |
27,648
| – | – | ﹤0.01% | 1274 |
|
|
2015
Q1 | $364K | Hold |
27,648
| – | – | ﹤0.01% | 1088 |
|
|
2014
Q4 | $274K | Buy |
+27,648
| New | +$274K | ﹤0.01% | 1168 |
|